日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Buffy Coat Enrichment Improves the Success Rate of Conventional Cytogenetics in Hypocellular Specimens: A Prospective Quality Improvement Study

白细胞层富集可提高低细胞标本常规细胞遗传学检测的成功率：一项前瞻性质量改进研究

期刊:Nature Immunology
影响因子:27.6
doi:10.1038/s41590-026-02501-x
Bai, Ziyi; Lan, Tianxia; Hong, Weiqi; Que, Haiying; Zhu, Min; Xiao, Xin; Wan, Dandan; Ai, Jiayuan; Huang, Shaoxiong; Wang, Jiayu; Hong, Qiaonan; Liu, Yanyan; Xiao, Chengxin; Zhao, Chengjian; Wang, Xin; Zhang, Xiaolong; Yang, Ting; Xu, Heng; Dai, Lunzhi; Powell, Charles A; Richeldi, Luca; Luo, Fengming; Dong, Haohao; Yuan, Yong; Pu, Qiang; Wei, Xiawei; Toruner, Gokce A; Imtiaz, Nawal; McCoy, Andrew M; Robinson, Melissa; Cardona, Griselda J; Delgado, Sarita S; Yang, Su; Wei, Qing; Medeiros, L Jeffrey; Tang, Guilin
细胞生物学
发表日期：2026
文献求助 收藏

Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway.

髓系巨噬细胞中溶酶体 TMEM175 的缺乏通过炎症小体和交叉呈递途径发挥抗肿瘤免疫作用。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-69546-2
Zhang Ziqi, Li Xue, Lu Tianqi, Yang Jingyun, Han Xuejiao, Bi Zhenfei, Luo Jingwen, Alu Aqu, Hong Weiqi, Chen Siyuan, Chen Lei, Cheng Yuan, He Xuemei, Zhu Chenjing, Wang Manni, Li Qingfang, Wang Yang, Li Lu, Lei Hong, Lan Jie, Geng Jia, Wei Yuquan, Wei Xiawei
细胞生物学
巨噬细胞
炎性小体
肿瘤免疫
炎症
巨噬细胞
发表日期：2026
文献求助 收藏

Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control

呼吸道合胞病毒（RSV）：从基础生物学到临床预防和控制的全面概述

期刊:Medicinal Research Reviews
影响因子:11.6
doi:10.1002/med.70025
Shi, Jie; Huang, Xiya; Ye, Chunjun; Lu, Yishan; Liu, Yanyan; Wei, Yuquan; Wei, Xiawei
微生物学
发表日期：2026
文献求助 收藏

Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin-Induced Lung Injury.

氧化的线粒体DNA导致博来霉素诱导的肺损伤中的肺部炎症和纤维化。

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70664
Mao Ye, Tian Xinyu, Ai Jiayuan, Zhou Xiaoting, Ni Yanghong, Wan Dandan, Luo Min, Wei Xiawei
炎症/感染
Immunology/Inflammation
炎症
线粒体
发表日期：2026
文献求助 收藏

Unsafe drinking water and human health: A global umbrella review of disease outcomes, intervention effectiveness, and policy implications

不安全饮用水与人类健康：疾病结局、干预效果和政策影响的全球性综述

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102588
Li, Shen; Wei, Yuhao; Zhou, Jingxuan; Li, Yifan; Qiao, Lichun; You, Diqing; Jiang, Yuting; Jiang, Zedong; Wei, Xiawei; Ma, Xuelei
发表日期：2026
文献求助 收藏

Combination of adenovirus vector and subunit protein elicits a robust immune response against the SARS-CoV-2 Omicron variant

腺病毒载体与亚单位蛋白的组合可诱导针对SARS-CoV-2 Omicron变异株的强效免疫反应。

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-026-00410-x
Ye, Chunjun; Huang, Xiya; Hong, Weiqi; Shi, Jie; Ao, Danyi; Zhang, Yu; Lu, Yishan; Zhou, Yingqiong; Song, Zhiruo; Zhang, Yu; Liu, Yanyan; Cheng, Ping; Lu, Guangwen; Li, Jiong; Song, Xiangrong; Wei, Xiawei
微生物学
SARS-CoV-2
免疫/内分泌
发表日期：2026
文献求助 收藏

Safety pharmacology and toxicology of a novel nitroimidazooxazole antitubercular agent in SD rat and Beagle dogs

新型硝基咪唑类抗结核药物在SD大鼠和比格犬中的安全性药理学和毒理学研究

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-026-00414-7
Peng, Dandan; Qin, Furong; Fu, Minyang; Jiang, Ning; Wang, Manni; Wang, Zhenling; Wei, Xiawei
Rat
发表日期：2026
文献求助 收藏

Role of LRRK2 in physiological activities, diseases, and therapy

LRRK2在生理活动、疾病和治疗中的作用

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003989
Wang, Zhuoran; Li, Qingfang; Yan, Lingxi; Du, Mingyu; Wei, Xiawei
LRRK2
发表日期：2026
文献求助 收藏

Association between endothelial activation and stress index and mortality in critically ill patients with atrial fibrillation: In MIMIC database: A Retrospective Cohort Study

内皮激活与应激指数和房颤危重患者死亡率之间的关联：基于MIMIC数据库的回顾性队列研究

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0342664
Zuo, Peiling; Zhu, Huanhuan; Sun, Chunying; Ma, Xiaohan; Chen, Sheng; Tang, Rong; Wu, Tong; Zhang, Ding; Tang, Xiao; Lv, Wenquan; Chen, Wenzhong; Wei, Xiawei; Hou, Encun; Wu, Minsheng; Jiang, Minghe
发表日期：2026
文献求助 收藏

A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial

一种新型抗结核药物展现出显著的临床疗效和良好的安全性：一项开放标签、随机对照、多中心 IIa 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02517-z
Chu, Naihui; Nie, Wenjuan; Du, Juan; Wang, Manni; Ma, Liping; Wang, Qingfeng; Wang, Jun; Hu, Xiaomeng; Wu, Jin; Lu, Yu; Huang, Mailing; Wei, Yuquan; Wang, Zhenling; He, Jian-Qing; Ding, Zhenyu; Wei, Xiawei
发表日期：2025
文献求助 收藏